News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Critically ill children more likely to die when underweight, but not when obese
By Linda Carroll (Reuters Health) - Being underweight may raise mortality risk among children who are critically ill, but being overweight appears to have no impact, a new study suggests. In an
Regeneron, Sanofi arthritis drug fails late-stage study in COVID-19 patients
By Reuters Staff (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a late-stage study testing it in COVID-
COVID-19 associated loss of smell, taste mostly resolves within weeks
By Linda Carroll (Reuters Health) - Most adults with a mild form of COVID-19 who have lost their ability to taste or smell as an early disease symptom will get those senses back, at least in part, a
Pharmacists expanded their antimicrobial stewardship role during pandemic
By Marilynn Larkin NEW YORK (Reuters Health) - To help limit hospital staff contact with SARS-CoV-2 patients, pharmacists at a university hospital consolidated the number of times medications needed
Aimmune says patients begin treatment with peanut allergy drug as COVID-19 lockdowns ease
By Carl O'Donnell and Manas Mishra (Reuters) - Aimmune Therapuetics Inc said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to
Health workers with appropriate PPE don't get COVID-19
By Lisa Rappaport (Reuters Health) - Health workers who have appropriate personal protective equipment (PPE) including protective suits, masks, gloves, goggles, face shields, and gowns don't develop
Sierra Leone doctors' strike leaves COVID-19 patients stranded
By Cooper Inveen Freetown (Reuters) - Doctors treating COVID-19 patients in Sierra Leone went on strike on Thursday over unpaid bonuses, leaving patients in some of the main treatment centres without
Moderna's COVID-19 vaccine trial delayed - STAT
By Reuters Staff (Reuters) - Shares of Moderna Inc fell 7% on Thursday after medical news site STAT reported a delay in a large trial testing the biotech's potential coronavirus vaccine as the company
NIH Director Collins optimistic on COVID-19 vaccine by year end
By Reuters Staff NEW YORK (Reuters) - The U.S. National Institutes of Health's director said on Thursday that he was optimistic that the Trump administration's vaccine-acceleration program, Operation
COVID-19 lockdowns pose weight-related health risks for obese people
By Lisa Rappaport (Reuters Health) - Many people with obesity who don't test positive for SARS-CoV-2 still face health risks from weight-related behaviors like less frequent or intense exercise, and
OCT angiography demonstrates retinal involvement in amblyopia
By Will Boggs MD NEW YORK (Reuters Health) - Optical coherence tomography angiography (OCT-A) could play a role in diagnosing and understanding the pathogenesis of amblyopia, researchers in Hong Kong
U.S. Supreme Court rebuffs abortion clinic protest zone challenges
By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday left in place policies in Chicago and Pennsylvania's capital Harrisburg that place limits on anti-abortion activists
Hospitals face visitor-restriction dilemmas for children during COVID-19
By Carolyn Crist NEW YORK (Reuters Health) - Hospitals that have imposed strict visitor restriction policies to stop the spread of COVID-19 may need to weigh the benefits and risks of allowing family
Liver fibrosis tied to ventilator need in COVID-19
By David Douglas NEW YORK (Reuters Health) - Middle-aged COVID-19 patients showing signs of advanced liver fibrosis, as estimated by the Fibrosis Index Based on 4 Factors (FIB-4), are at greater
Telephone interventions might relieve some symptoms in adults with cancer
By Will Boggs MD NEW YORK (Reuters Health) - Telephone interventions offer some relief of depression and other symptoms in adults with cancer, but the certainty of evidence is generally low, according
Florida shatters records with over 10,000 new COVID-19 cases in single day
By Lisa Shumaker (Reuters) - Florida shattered records on Thursday when it reported over 10,000 new coronavirus cases, the biggest one-day increase in the state since the pandemic started, according
ART regimen linked to lower COVID-19 risk in people with HIV
By Anne Harding NEW YORK (Reuters Health) - COVID-19 incidence and severity are lower in people with HIV who are taking tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) compared to those on
U.S. Supreme Court sends Indiana abortion cases back to lower courts
By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday sent two Indiana abortion disputes back to lower courts including a fight over a restriction that would require women to
European agency backs synthetic crab blood for medical safety tests
By Reuters Staff ZURICH (Reuters) - Companies can use a synthetic alternative to the blood of horseshoe crabs in safety tests for medical products, a European agency has ruled, in a boost for wildlife
REFILE-COVID-19 related MIS-C in kids can spark a treatable type of heart failure
(Refiling 5/21 story to address formatting issues experienced by some clients.) By Linda Carroll (Reuters Health) - Researchers have described the diagnoses and treatment as well as initial warning
Tesla to make molecule printers for German COVID-19 vaccine developer CureVac
By Reuters Staff (Reuters) - Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive
EXPLAINER-How U.S. airlines are trying to stop COVID-19 on flights
By Tracy Rucinski CHICAGO (Reuters) - As some Americans prepare to travel for the July 4 holiday weekend, and airlines slowly ramp up service, the U.S. government has not changed rules for air travel
COVID-19 strain in recent Beijing outbreak may have come from SE Asia
By Reuters Staff SHANGHAI (Reuters) - A strain of COVID-19 that has infected more than 300 people in Beijing since early June could have originated in South or Southeast Asia, according to a study by
As cases in Tokyo surge, Japan gives expert advisory panel a makeover
By Rocky Swift and Linda Sieg TOKYO (Reuters) - With new coronavirus cases in Tokyo surging to a two-month high, Japan faces the prospect of a second wave without the experts who tackled the first
Proportion of COVID-19 contacts reached by English test and trace scheme falls
By Reuters Staff LONDON (Reuters) - Less than three-quarters of close contacts of positive COVID-19 cases identified by England's test and trace system were reached in the latest weekly figures,
Popular fireworks release toxic metals into the air
By Linda Carroll (Reuters Health) - Commonly used fireworks release metals such as lead and titanium into the air as they explode, with potentially adverse effects on human lungs, a new study suggests
Mild liver enzyme increases seen in COVID-19 patients in China
By Marilynn Larkin NEW YORK (Reuters Health) - Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise
U.S. primary care shutdown losses projected at $15 billion
By Lisa Rappaport (Reuters Health) - Primary care practices are projected to have combined revenue losses of $15.1 billion due to dramatic declines in office visits from March to May 2020 during COVID
Left atrial appendage closure noninferior to DOACs for afib when bleeding risk is high
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with atrial fibrillation at high risk for stroke and bleeding, percutaneous left atrial appendage closure (LAAC) was noninferior to direct
Brazil to test Sinovac's potential vaccine against COVID-19 in six states
By Reuters Staff SAO PAULO (Reuters) - A potential coronavirus vaccine developed by China's Sinovac will be tested in Brazil by 12 research centers in 6 Brazilian states, the governor of Sao Paulo
'We are not guinea pigs,' say South African anti-vaccine protesters
By Reuters Staff JOHANNESBURG (Reuters) - Anti-vaccine protesters took to the streets in Johannesburg on Wednesday to voice their concern over Africa's first human trials for a potential coronavirus
World takes stock of COVID-19 drug remdesivir after U.S. snaps up supplies
By Sangmi Cha, Andreas Rinke and Alistair Smout SEOUL/BERLIN/LONDON (Reuters) - Some governments in Europe and Asia said on Wednesday they have enough of Gilead's COVID-19 anti-viral remdesivir for
COVID SCIENCE-Blood cell damage may explain low oxygen levels; two vaccines show promise in early testing
By Nancy Lapid The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the
WHO warns some nations still face 'long, hard' battle with COVID-19
By Emma Farge and John Revill GENEVA (Reuters) - Nations who fail to use every mechanism available to combat the still-raging novel coronavirus will struggle to beat it, the World Health Organization
As Japan re-opens, a hospital grapples with coronavirus aftermath
By Mari Saito and Ami Miyazaki YOKOHAMA (Reuters) - Doctors in white coats and blue scrubs sat around a conference room table in June, looking up at a colourful slide projected on the wall. "How is
Oxford COVID-19 vaccine developers encouraged by immune response but cautious on timeframe
By Reuters Staff LONDON (Reuters) - A leading scientist behind the University of Oxford's potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials but
Liquid biopsy promising in spotting kidney cancer
By David Douglas NEW YORK (Reuters Health) - An assay employing plasma and urine cell-free (cf) DNA methylomes is capable of classifying patients across all stages of renal-cell carcinoma (RCC),
Replacing N95 masks with P100 elastomeric masks could save money during pandemic
By Scott Baltic NEW YORK (Reuters Health) - Replacing disposable N95 masks with industrial-style elastomeric masks that use disposable P100 filters is practical and cost-saving, a trial program at a
Liver complications common with COVID-19
By Will Boggs MD NEW YORK (Reuters Health) - Liver complications are common and are associated with more severe disease in patients with COVID-19, according to a new review. "The data confirms that
Statin therapy tied to lower risk of dying from ovarian cancer
By Megan Brooks NEW YORK (Reuters Health) - In a large observational study of women with epithelial ovarian cancer, use of a cholesterol-lowering statin was associated with a significant reduction in
Brains of older adults often harbor four common proteinopathies
By Reuters Staff NEW YORK (Reuters Health) - The presence of four misfolded proteins linked to neurodegeneration is common in the brains of older adults and is associated with dementia and impaired
COVID-19 stress could increase mental-health risks for kids, teens
By Carolyn Crist NEW YORK (Reuters Health) - The COVID-19 pandemic will continue to affect vulnerable groups of children, especially those who are homeless, in foster care, struggle with substance-use
Digital health aids electrophysiology practice during COVID-19 pandemic and beyond
By Will Boggs MD NEW YORK (Reuters Health) - Digital health can facilitate electrophysiology practice for patients with arrhythmia during and after the COVID-19 pandemic, according to an international
U.S. COVID-19 deaths likely higher than reported -U.S. study
By Deena Beasley (Reuters) - The number of Americans who died from COVID-19 in March through May was likely significantly higher than the official U.S. count due in part to state-level reporting
FACTBOX-New drug launches stalled by COVID-19 pandemic
By Carl O'Donnell and Manas Mishra (Reuters) - The U.S. Food and Drug Administration has approved more than 30 new drugs since January. So far, five medicines have seen their commercial launches
FOCUS-From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
By Carl O'Donnell and Manas Mishra (Reuters) - Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers
U.S. FDA issues guidance for COVID-19 vaccine approval
By Manojna Maddipatla and Dania Nadeem (Reuters) - The U.S. Food and Drug Administration on Tuesday released guidance for approving a coronavirus vaccine, saying the vaccine has to prevent or decrease
BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well
Patients misconstrue terms clinicians use to discuss kidney health
By Lisa Rappaport (Reuters Health) - Many patients may not understand terms like "end-stage kidney disease," which adds to their distress and even trauma when discussing renal health with clinicians,
Neonatal SARS-CoV-2 may present with hypoxemia without respiratory distress
By Lisa Rappaport (Reuters Health) - Neonatal SARS-CoV-2 infection may present in the first days of life with clinically significant hypoxemia in a newborn that doesn't have overt signs of respiratory
Combined oral contraceptives tied to increased bone mass in premature ovarian insufficiency
By Marilynn Larkin NEW YORK (Reuters Health) - In women with premature ovarian insufficiency (POI), combined oral contraceptives (COCs) use was associated with increased bone mineral density (BMD)
Scottish firm to trial T cells as possible COVID-19 treatment
By Reuters Staff LONDON (Reuters) - A Scottish biotechnology firm said on Tuesday it would start clinical trials on a possible T cell treatment for COVID-19, aimed at reducing the need for intensive
Bavaria's free COVID-19 test for all splits Germany
By Joseph Nasr BERLIN (Reuters) - The state of Bavaria approved plans on Tuesday for universal testing for COVID-19, prompting debate elsewhere in Germany about whether to follow suit or stick with
Drugs, doctors and donors: Pakistanis turn to 'Corona Warriors' Facebook group
By Umar Farooq ISTANBUL (Reuters) - When musician Zoraiz Riaz set up a Facebook group to help coordinate convalescent plasma donations for people fighting COVID-19 in Pakistan, he expected perhaps a
Inovio's COVID-19 vaccine candidate shows promise in small early-stage trial
By Trisha Roy and Manas Mishra (Reuters) - An experimental coronavirus vaccine developed by Inovio Pharmaceuticals Inc showed promise and was found to be safe in an early-stage human trial, the
U.S. top medical experts rebuke American Airlines for filling planes
By David Shepardson and Tracy Rucinski WASHINGTON/CHICAGO (Reuters) - Top U.S. health experts on Tuesday criticized American Airlines and other carriers for filling planes to capacity, saying it sends
Fauci says no guarantee U.S. will have effective COVID-19 vaccine, warns spread 'could get very bad'
By Paul Simao and Carl O'Donnell WASHINGTON (Reuters) - The United States cannot count on the availability of a safe and effective COVID-19 vaccine, the government's top infectious diseases expert
Sweden starts critical look at its pandemic response
By Reuters Staff STOCKHOLM (Reuters) - Sweden on Tuesday announced a commission to evaluate its response to the novel coronavirus, reacting to criticism over a death toll that has far exceeded that of
Young adults with early-onset cancer may benefit from genetic testing
By Megan Brooks NEW YORK (Reuters Health) - Young adults with early-onset cancers often harbor germline mutations and would benefit from germline genetic testing, according to a new study. "Although
Tanezumab has small effect on difficult-to-treat chronic low-back pain, may cause joint problems in some
By Will Boggs MD NEW YORK (Reuters Health) - Tanezumab produces a small reduction in pain and improves function in patients with chronic low-back pain not adequately controlled by standard-of-care
Glucose-lowering drugs equally effective as initial treatment for type 2 diabetes
By Will Boggs MD NEW YORK (Reuters Health) - Metformin and other monotherapies for type 2 diabetes have similar effectiveness as initial treatment for patients at low cardiovascular risk, according to
Researchers find no sign of link between chilblains, SARS-CoV-2 infection
By Will Boggs MD NEW YORK (Reuters Health) - Although several adults and children have developed chilblains during the COVID-19 pandemic, two new European case series find no evidence of a causal link
Better data shed more light on ulcerative colitis surgery
By Reuters Staff NEW YORK (Reuters Health) - An inflammatory bowel disease (IBD) surgery registry that adds IBD-specific variables to general quality measurements for restorative proctocolectomy with
MS patients on disease-modifying therapies have lower risk of severe COVID-19
By Reuters Staff NEW YORK (Reuters Health) - Age, obesity and disease severity are the most important independent risk factors for severe COVID-19 in people with multiple sclerosis (MS), while
Global COVID-19 prevention trial of hydroxychloroquine to resume
By Kate Kelland LONDON (Reuters) - A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being
Six months after 'viral pneumonia', Wuhan returning to normal, with masks
By Xihao Jiang and Martin Quin Pollard WUHAN, China/BEIJING (Reuters) - Six months after the World Health Organization learned of "viral pneumonia" cases that would become the COVID-19 pandemic, life
China study warns of new flu virus in pigs with pandemic potential
By David Stanway SHANGHAI (Reuters) - A new flu virus found in Chinese pigs has features that make it more infectious to humans and needs to be watched closely in case it becomes a potential pandemic
Italian whole-town study finds 40% of coronavirus cases had no symptoms
By Kate Kelland LONDON (Reuters) - A study of coronavirus infections that covered almost everyone in the quarantined north Italian town of Vò found that 40% of cases showed no symptoms - suggesting
EXCLUSIVE-After pandemic, U.S. senators want review of drug supply chain
By Patricia Zengerle WASHINGTON (Reuters) - Republican and Democratic U.S. senators called for a government analysis of foreign influence in the U.S. pharmaceutical supply chain on Tuesday, saying the
Nurse understaffing and increased workload associated with multiple organ failure
By Lisa Rappaport (Reuters Health) - Lower nurse staffing levels and increased nurse workload are associated with a greater proportion of patients with multiple organ failure, a Finnish study suggests
Masked Madrid health workers sing, weep and call for job security
By Reuters Staff MADRID (Reuters) - Health workers in scrubs and face masks gathered in central Madrid's Puerta del Sol Square on Monday, demanding better terms for work in a system that was
Nobel laureates call for coronavirus vaccines to be available for all
By Darnell Christie LONDON (Thomson Reuters Foundation) - Nobel peace laureate Desmond Tutu and actor George Clooney are among more than 100 people who have signed an appeal for COVID-19 vaccines to
COVID SCIENCE-'Tentacles' on cells may help virus spread to other cells; risk not significantly higher in people with HIV
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness
Patients with pulmonary disease shouldn't quit aerosolized medication over COVID fears
By Linda Carroll (Reuters Health) - COVID-19 concerns should not stop patients from using inhaled corticosteroids, a new commentary article suggests. While patients with pulmonary diseases are at
Exercise intolerance tied to worse quality of life for childhood cancer survivors
By Lisa Rappaport (Reuters Health) - Adult survivors of childhood cancer who are exercise intolerant are also more likely to have mental health problems, a recent study suggests. Researchers examined
Radical prostatectomy curbs cancer risks but ups adverse events compared with waiting, monitoring
By Marilynn Larkin NEW YORK (Reuters Health) - Men with localized prostate cancer will likely have better oncological outcomes from radical prostatectomy (RP) versus deferring treatment, but they are
Novel regenerative approach shows promise for Parkinson's disease
By Marilynn Larkin NEW YORK (Reuters Health) - A single-step method that converts astrocytes into functional dopaminergic neurons could one day be used to treat Parkinson's and other neurodegenerative
REFILE-UPDATE 1-Some U.S. Sun Belt states backtrack after flouting pandemic guidelines
(Adds dateline) By Susan Heavey and Maria Caspani Washington/New York (Reuters) - The recent spike in U.S. coronavirus infections has been fueled in large part by Americans ignoring public health
UPDATE 1-Some U.S. Sun Belt states backtrack after flouting pandemic guidelines
(Adds White House on masks, movie theater chain reopening postponed) By Susan Heavey and Maria Caspani The recent spike in U.S. coronavirus infections has been fueled in large part by Americans
HIV treatment found to have no benefit for hospitalised COVID-19 patients in trial
By Reuters Staff LONDON (Reuters) - A combination of antiviral drugs used to treat HIV had no beneficial effect in patients hospitalised with COVID-19 in a large-scale randomised trial, British
CORRECTED-'Wear a mask!' Republicans change tune as COVID-19 surges
(Corrects to Tim, from Rick, in paragraph 4) By Doina Chiacu WASHINGTON (Reuters) - Republican lawmakers are making a public push for face coverings, splitting with mask-averse U.S. President Donald
Canada over worst of coronavirus outbreak, U.S. spike a cause for concern -Trudeau
By David Ljunggren and Kelsey Johnson OTTAWA (Reuters) - Canada is over the worst of the coronavirus outbreak but a spike in cases in the United States and elsewhere shows Canadians must remain
Many Chinese patients stopped IBD meds during COVID-19 pandemic
By Will Boggs MD NEW YORK (Reuters Health) - Many patients stopped taking drugs for inflammatory bowel disease (IBD) during the COVID-19 pandemic in China, which often resulted in disease aggravation,
Pandemic 'is not even close to being over', WHO chief says
By Emma Farge GENEVA (Reuters) - The COVID-19 pandemic is not even close to being over, World Health Organization chief Tedros Adhanom Ghebreyesus told a briefing on Monday. Tedros noted that, six
'Wear a mask!' Republicans change tune as COVID-19 surges
By Doina Chiacu WASHINGTON (Reuters) - Republican lawmakers are making a public push for face coverings, splitting with mask-averse U.S. President Donald Trump on the issue, as COVID-19 cases surge in
UPDATE 1-U.S. Supreme Court strikes down Louisiana abortion clinic restrictions
(Adds reaction from anti abortion and abortion rights groups and more from ruling, more background on law at issue) By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court defended abortion
Kidney problems common in children with COVID-19
By Reuters Staff NEW YORK (Reuters Health) - Kidney dysfunction appears to be common among children and adolescents hospitalized with COVID-19, researchers in the UK report. About 7% of adult COVID-19
Germany uncovers massive online child abuse network
By Reuters Staff BERLIN (Reuters) - German cyber crime authorities have uncovered a massive online network of at least 30,000 people who share child pornography and exchange advice on how to sedate
'A recipe for disaster,' U.S. health official says of Americans ignoring coronavirus advice
By Susan Heavey and Doina Chiacu WASHINGTON (Reuters) - A spike in U.S. coronavirus infections is fueled in large part by people ignoring public health guidelines to keep their distance and wear masks
U.S. Supreme Court strikes down Louisiana abortion clinic restrictions
By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court defended abortion rights in a major ruling on Monday by striking down a Louisiana law placing restrictions on doctors who perform the
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient
By Manojna Maddipatla and Ludwig Burger (Reuters) - Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other
The British are fatter than the rest of Europe, says PM Johnson
By Guy Faulconbridge and Elizabeth Piper LONDON (Reuters) - The British are far fatter than any other nation in Europe bar the Maltese so there needs to be a debate about how to tackle soaring rates
U.S. teens advise schools on fall reopening during COVID-19 pandemic
By Alicia Powell and Barbara Goldberg NEW YORK (Reuters) - When U.S. schools begin the next academic year with the country still fighting the coronavirus pandemic, students should spend half their
Adjuvant immunotherapy tied to survival benefit in advanced melanoma
By Megan Brooks NEW YORK (Reuters Health) - Immunotherapy following surgery for stage-3 melanoma is associated with longer survival, but not all patients receive it, according to the first analysis of
Risk of nephrogenic systemic fibrosis appears low with newer gadolinium agents
By Will Boggs MD NEW YORK (Reuters Health) - The risk of developing nephrogenic systemic fibrosis (NSF) after exposure to gadolinium agents appears to be low, at least among people with normal kidney
COVID-19 shutdowns hurt, could close medical practices
By Carolyn Crist NEW YORK (Reuters Health) - Doctor's offices have landed on the list of U.S. small businesses that continue to face financial difficulties during the COVID-19 pandemic, according to a
Retinopathy risk increased in T2DM after cataract surgery
By Anne Harding NEW YORK (Reuters Health) - People with type-2 diabetes are more likely to develop diabetic retinopathy (DR) after cataract surgery, according a new population-based study. Over six
Britain's COVID-19 app: The game changer that wasn't
By Steve Stecklow LONDON (Reuters) - As Britain's COVID-19 infections soared in the spring, the government reached for what it hoped could be a game changer – a smartphone app that could automate some
SPECIAL REPORT-Into the fog: How Britain lost track of the coronavirus
By Stephen Grey, Andrew MacAskill, Ryan McNeill, Steve Stecklow and Tommy Wilkes LONDON(Reuters) - On Friday, Feb. 21, Duncan Selbie, chief executive of Public Health England, was in a cheerful mood.
Italian study shows lower viral load in COVID-19 patients in May than April peak
By Emilio Parodi MILAN (Reuters) - A small study by researchers in Italy has found that COVID-19 patients who were tested for the novel coronavirus at a hospital there in May had fewer virus particles
